Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Arbutus Biopharma Corp’s current trading price is -30.37% away from its 52-week high, while its distance from the 52-week low is 43.04%. The stock’s price range over this period has fluctuated between $2.30 and $4.72. The company, operating within the financial sector, had a trading volume of approximately 0.4 million for the day, which was noticeably lower than the average daily share volume of 0.81 million over the last 3 months.
The market performance of Arbutus Biopharma Corp’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $4.72 on 09/09/24, while the lowest value for the same duration was $2.30 on 04/03/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Arbutus Biopharma Corp (ABUS) has experienced a quarterly decline of -9.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 623.42M and boasts a workforce of 73 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.59, with a change in price of -0.73. Similarly, Arbutus Biopharma Corp recorded 819,955 in trading volume during the last 100 days, posting a change of -18.16%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ABUS stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.06.
ABUS Stock Stochastic Average
Today, Arbutus Biopharma Corp’s raw stochastic average for the past 50 days stands at 26.47%, indicating a decline from the raw stochastic average of the last 20 days, which was 28.57%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 30.77% and 32.91% respectively.
ABUS Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price increase of 0.61%. However, over the past six months, we’ve seen a stronger performance of -10.60%. The price of ABUS fallen by 0.30% over the last 30 days. And in the last five days, it has fallen by -4.08%.
